Loading...

Liquidia Corporation

LQDA•NASDAQ
Healthcare
Biotechnology
$37.31
$-0.15(-0.40%)
U.S. Market opens in 49h 27m

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.3B
P/E Ratio-47.03
EPS (TTM)$-0.80
ROE-2.09%
Fundamental Analysis

AI Price Forecasts

1 Month$33.83
3 Months$43.76
1 Year Target$49.34

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -47.03 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.40%
5-Day Change
-9.88%
1-Month Change
5.99%
3-Month Change
-8.08%
6-Month Change
66.71%
Year-to-Date (YTD) Change
8.18%
1-Year Change
165.93%
3-Year Change
448.68%
5-Year Change
1195.49%
All-Time (Max) Change
236.13%

Contact Information

https://www.liquidia.com
919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions